Table 2 The relationship between positive rate of CTCs and clinical characteristics
Characteristics | No. of patients with positive CTCs (%) | |
|---|---|---|
Newly diagnosis (M0, N = 29) | Relapse/Distant metastasis after treatment (N = 21) | |
Gender | ||
 Male | 17 (89.5) | 14 (93.3) |
 Female | 10 (100.0) | 5 (83.3) |
Age (years) | ||
  < 50 | 16 (94.1) | 11 (91.7) |
  ≥ 50 | 11 (91.7) | 8 (88.9) |
Pathology type | ||
 WHO I | 1 (100.0) | – |
 WHO II/III | 26 (92.9) | 19 (90.5) |
TNM stagea | ||
 I | – | – |
 II | 1 (50.0) | 2 (100.0) |
 III | 11 (91.7) | 6 (85.7) |
 IV | 15 (100.0) | 11 (91.7) |